Neo Ivy Capital Management Baxter International Inc Transaction History

Neo Ivy Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 24, 2023	BUY	$49.7 - $57.71 $437,161 - $507,617	8,796 Added 1370.09%	9,438 $481,000
Q3 2022 Nov 15, 2022	SELL	$53.86 - $66.8 $65,655 - $81,429	-1,219 Reduced 65.5%	642 $35,000
Q2 2022 Aug 16, 2022	SELL	$63.83 - $80.0 $14,106 - $17,680	-221 Reduced 10.61%	1,861 $119,000
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $160,001 - $186,234	2,082 New	2,082 $162,000
Q4 2021 Feb 15, 2022	SELL	$74.57 - $87.19 $242,277 - $283,280	-3,249 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$73.77 - $83.61 $446,160 - $505,673	-6,048 Reduced 65.05%	3,249 $280,000
Q2 2021 Aug 16, 2021	BUY	$80.5 - $88.01 $748,408 - $818,228	9,297 New	9,297 $748,000
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $607,869 - $664,068	-8,063 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$78.33 - $90.73 $631,574 - $731,555	8,063 New	8,063 $648,000
Q2 2020 Aug 17, 2020	SELL	$78.66 - $94.14 $255,566 - $305,860	-3,249 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$78.66 - $94.14 $149,139 - $178,489	1,896 Added 140.13%	3,249 $280,000
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $96,834 - $126,234	1,353 New	1,353 $110,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.